6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)- manufacturers
|
| | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)- Basic information |
| Product Name: | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)- | | Synonyms: | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)-;Fluvastatin potassium | | CAS: | 1009811-63-5 | | MF: | C24H26FNO4.K | | MW: | 450.57 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)- Structure]() |
| | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)- Chemical Properties |
| | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)- Usage And Synthesis |
| Uses | (3S,5R)-Fluvastatin (potassium) is a synthetic hypolipidemic drug that inhibits HMG-CoA reductase activity. (3S,5R)-Fluvastatin (potassium) has similar antioxidative effects on copper ion-induced LDL oxidation compared to its 3R,5S enantiomer. (3S,5R)-Fluvastatin (potassium) and its metabolites demonstrate a potential to exhibit anti-atherosclerotic effects through their antioxidative activities. (3S,5R)-Fluvastatin (potassium) is clinically utilized as part of a racemic mixture for reducing plasma cholesterol levels. | | References | [1] In vitro inhibitory effects of the optical isomers and metabolites of fluvastatin on copper ion-induced LDL oxidation DOI:10.1248/bpb.22.971 |
| | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, potassium salt (1:1), (3S,5R,6E)- Preparation Products And Raw materials |
|